T46.8
Poisoning by, adverse effect of and underdosing of antivaricose drugs, including sclerosing agents
Clinical Classification Guidelines
Medical Intelligence & Overview
ICD-10 code T46.8 refers to cases involving poisoning, adverse effects, or underdosing of antivaricose drugs, including sclerosing agents. These medications are commonly used to treat varicose veins and related conditions. While effective, improper use or overdose can lead to complications that require medical attention. This overview offers a patient-friendly explanation of what this code encompasses, highlighting causes, symptoms, and general approaches to diagnosis and treatment.
Causes & Symptoms
Clinical Causes: Overdose of antivaricose medications, especially sclerosing agents used for vein treatment Unintentional ingestion or improper administration of these drugs Adverse reactions due to hypersensitivity or allergic responses to the medication Medication interactions that increase toxicity or adverse effects Incorrect dosage, either too high or too low, leading to toxicity or ineffective treatment
Key Symptoms: Pain, swelling, or redness at the site of injection or treatment area Skin discoloration or necrosis around treated veins Signs of systemic toxicity such as nausea, vomiting, or dizziness Allergic reactions including rash, itching, or difficulty breathing Unusual fatigue or weakness Possible development of ulcers or tissue damage if the adverse effect is severe
Diagnostic & Treatment
Diagnosis Path: Medical professionals typically determine the diagnosis based on a patient's recent use of antivaricose treatments and the presentation of symptoms. They may perform
Treatment Protocols: Management of poisoning or adverse effects from antivaricose drugs depends on the severity of symptoms. Approaches may include
Clinical Advice & FAQs
Billing Guidance
Is T46.8 a billable ICD-10 code?
Yes, T46.8 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report T46.8?
Clinical documentation must specify the nature of Poisoning by, adverse effect of and underdosing of antivaricose drugs, including sclerosing agents and any associated comorbidities for accurate reporting.
Cite this Clinical Reference